Articles from Robbins LLP
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of the American Depository Receipts ("ADRs") of GSK PLC (NYSEGSK) between February 5, 2020 and August 14, 2022. GSK is a global pharmaceutical company that develops, manufactures, and markets vaccines and medicines worldwide.
By Robbins LLP · Via GlobeNewswire · February 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all purchasers of Monolithic Power Systems Inc. (NASDAQMPWR) common stock between February 8, 2024 and November 8, 2024. Monolithic is a provider of power management components used in electronic systems.
By Robbins LLP · Via GlobeNewswire · February 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Newmont Corporation (NYSENEM) securities between February 22, 2024 and October 23, 2024. Newmont is the world’s leading gold mining company and producer of copper, silver, zinc and lead.
By Robbins LLP · Via GlobeNewswire · February 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Target Corporation (NYSETGT) stock between August 26, 2022 and November 19, 2024. Target Corporation operates general merchandise discount stores in the United States.
By Robbins LLP · Via GlobeNewswire · February 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Transocean Ltd. (NYSERIG) securities between October 13, 2023 and September 2, 2024. Transocean, together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide.
By Robbins LLP · Via GlobeNewswire · February 5, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Walgreens Boots Alliance, Inc. (NYSEWBA) common stock between April 2, 2020 and January 16, 2025. Walgreens operates as a healthcare, pharmacy, and retail company in the U.S., the United Kingdom, Germany, and internationally.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ModivCare, Inc. (NASDAQMODV) securities between November 3, 2022 and September 15, 2024. ModivCare provides a suite of integrated supportive care solutions for public and private payors and their members.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons or entities who purchased or otherwise acquired Polestar Automotive Holding UK PLC (NASDAQPSNY) securities between November 14, 2022 and January 16, 2025. Polestar purports to be “the Swedish electric performance car brand with a focus on uncompromised design and innovation, and the ambition to accelerate the change towards a sustainable future.”
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Nextracker Inc. (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024. Nextracker provides software that enables solar panels to follow the sun's movement across the sky and related products and services.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired TELUS International (Cda) Inc. (NYSETIXT) securities between February 16, 2023 and August 1, 2024. TELUS International purports to design, build, and deliver digital solutions for customer experience, including artificial intelligence (“AI”) services, cloud solutions, and user experience/user interface design.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons who sold shares if Arconic Corporation (NYSEARNC) common stock between April 19, 2022 and May 3, 2023. Arconic was a publicly-traded provider of aluminum sheets, plates, and extrusions, as well as innovative architectural products, that advance the ground transportation, aerospace, building and construction, industrial, and packaging end markets. Apollo acquired Arconic and assumed Arconic’s obligations on August 18, 2023.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Cardlytics, Inc. (NASDAQCDLX) securities between March 14, 2024 and August 7, 2024. Cardlytics operates an advertising platform in the U.S. and the U.K.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased shares of Integral Ad Science Holding Corp. (NASDAQIAS) common stock between March 2, 2023 and February 27, 2024. IAS is a global software company specializing in digital advertising.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Grocery Outlet Holding Corp. (NASDAQGO) securities between November 7, 2023 and May 7, 2024. Grocery Outlet is a value retailer of consumables and fresh products sold via a network of independently operated stores across the U.S.
By Robbins LLP · Via GlobeNewswire · February 3, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Block, Inc. (NYSESQ) Class A common stock between February 26, 2020 and April 30, 2024. Block is a financial technology conglomerate.
By Robbins LLP · Via GlobeNewswire · January 31, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSEIIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust (“REIT”) purportedly focused on the acquisition, ownership, and management of specialized properties leased to state-licensed operators for their regulated medical-use cannabis facilities.
By Robbins LLP · Via GlobeNewswire · January 31, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira BioSciences, Inc. (NASDAQPCRX) securities between August 2, 2023 and August 8, 2024. Pacira is an American pharmaceutical company committed to developing and providing non-opioid pan management and regenerative health solutions.
By Robbins LLP · Via GlobeNewswire · January 31, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired FTAI Aviation Ltd. (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025. FTAI owns and acquires aviation and offshore energy equipment.
By Robbins LLP · Via GlobeNewswire · January 31, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 28, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Novo Nordisk A/S (NYSENVO) securities between November 2, 2022 and December 19, 2024. Novo is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.
By Robbins LLP · Via GlobeNewswire · January 28, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired ESSA Pharma Inc. (NASDAQEPIX) securities between December 12, 2023 and October 31, 2024. ESSA is a clinical stage pharmaceutical company that focuses on the development of small molecule drugs for the treatment of prostate cancer. The Company's lead product candidate was masofaniten, which was in clinical trial in combination with enzalutamide compared with enzalutamide alone in patients with metastatic CRPC.
By Robbins LLP · Via GlobeNewswire · January 28, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of purchasers of DMC Global Inc. (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024. DMC Global is a diversified industrial company.
By Robbins LLP · Via GlobeNewswire · January 24, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired FTAI Aviation Ltd. (NASDAQFTAI) securities between July 23, 2024 and January 15, 2025. FTAI owns and acquires aviation and offshore energy equipment.
By Robbins LLP · Via GlobeNewswire · January 24, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action against Kyverna Therapeutics, Inc. (NASDAQKYTX) and certain of the Company's senior executives and directors who signed the Registration Statement, effective February 7, 2024, issued in connection with the Company's initial public offering ("IPO"). Kyverna is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases.
By Robbins LLP · Via GlobeNewswire · January 24, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Innovative Industrial Properties, Inc. (NYSEIIPR) securities between February 27, 2024 and December 19, 2024. IIPR is an internally managed real estate investment trust (“REIT”) purportedly focused on the acquisition, ownership, and management of specialized properties leased to state-licensed operators for their regulated medical-use cannabis facilities.
By Robbins LLP · Via GlobeNewswire · January 22, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
By Robbins LLP · Via GlobeNewswire · January 22, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQAZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as "a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology."
By Robbins LLP · Via GlobeNewswire · January 22, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
By Robbins LLP · Via GlobeNewswire · January 17, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 17, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (NASDAQMU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices.
By Robbins LLP · Via GlobeNewswire · January 17, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQREGN) securities between November 2, 2023 and October 30, 2024. Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
By Robbins LLP · Via GlobeNewswire · January 17, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Micron Technology, Inc. (NASDAQMU) securities between September 28, 2023 and December 18, 2024. Micron designs, develops, manufactures, and sells memory and storage products, including, inter alia, dynamic random access memory (“DRAM”), NAND, NOR, and high-bandwidth memory (“HBM”) semiconductor devices.
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of purchasers of DMC Global Inc. (NASDAQBOOM) securities between May 3, 2024 and November 4, 2024. DMC Global is a diversified industrial company.
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Caribou Biosciences, Inc. (NASDAQCRBU) securities between July 14, 2023 and July 16, 2024. Caribou is a clinical-stage biopharmaceutical company that purports to develop genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the U.S. and internationally.
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or sold Capri Holdings Limited (NYSECPRI) stock between August 10, 2023 and October 24, 2024. Capri is a fashion firm.
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired AstraZeneca PLC (NASDAQAZN) securities between February 23, 2022 and December 17, 2024. AstraZeneca describes itself as "a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and Biopharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology."
By Robbins LLP · Via GlobeNewswire · January 13, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all shareholders who purchased stock pursuant and/or traceable to the BioAge Labs, Inc. (NASDAQBIOA) registration statement for the initial public offering (IPO) held on September 26, 2024. BioAge claims it is a "clinical stage biopharmaceutical company” that develops therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging.
By Robbins LLP · Via GlobeNewswire · January 8, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Regeneron Pharmaceuticals, Inc. (NASDAQREGN) securities between November 2, 2023 and October 30, 2024. Regeneron is a biotechnology company that designs products for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, among others.
By Robbins LLP · Via GlobeNewswire · January 8, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired MGP Ingredients, Inc. (NASDAQMGPI) common stock between May 4, 2023 and October 30, 2024. MGPI is a company that manufactures, distills, and sells alcoholic beverages such as tequila, bourbon, rye, and other whiskeys, as well as grain-neutral spirits such as vodka and gin.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Symbotic Inc. (NASDAQSYM) securities between February 8, 2024 and November 26, 2024. Symbotic is an automation technology company that engages in the production of a robotics and automation-based product movement technology platform.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Sun Communities, Inc. (NYSESUI) for wrongdoing between February 28, 2019 and September 24, 2024. Sun Communities is a real estate investment company that focuses its investments on manufactured housing communities, recreational vehicle communities, and marinas.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Cassava Sciences, Inc. (NASDAQSAVA) for wrongdoing between February 7, 2024 and November 24, 2024. Cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired ASP Isotopes Inc. (NASDAQASPI) securities between October 30, 2024 and November 26, 2024. ASP Isotopes is a development stage advanced materials company focused on the production, enrichment, and sale of isotopes.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
By Robbins LLP · Via GlobeNewswire · January 6, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (NASDAQENPH) securities between April 25, 2023 and October 22, 2024. Enphase develops, manufactures, and sells solar microinverters, which are primarily used in residential solar installations to convert solar panel output from direct current to alternating current (which can be transmitted to the power grid).
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Cassava Sciences, Inc. (NASDAQSAVA) for wrongdoing between February 7, 2024 and November 24, 2024. Cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons who purchased or sold Capri Holdings Limited (NYSECPRI) stock between August 10, 2023 and October 24, 2024. Capri is a fashion firm.
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Caribou Biosciences, Inc. (NASDAQCRBU) securities between July 14, 2023 and July 16, 2024. Caribou is a clinical-stage biopharmaceutical company that purports to develop genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the U.S. and internationally.
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Transocean Ltd. (NYSERIG) securities between October 13, 2023 and September 2, 2024. Transocean, together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide.
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Nextracker Inc. (NASDAQNXT) common stock between February 1, 2024 and August 1, 2024. Nextracker provides software that enables solar panels to follow the sun's movement across the sky and related products and services.
By Robbins LLP · Via GlobeNewswire · January 2, 2025
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Zeta Global Holdings Corp. (NYSEZETA) securities between February 27, 2024 and November 13, 2024. Zeta is a marketing technology company.
By Robbins LLP · Via GlobeNewswire · December 26, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Xerox Holdings Corporation (NASDAQXRX) securities between January 25, 2024 and October 28, 2024. Xerox and its subsidiaries offer workplace technology that integrates hardware, services, and software for enterprises in the Americas, and internationally.
By Robbins LLP · Via GlobeNewswire · December 26, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Visa Inc. (NYSEV) securities between November 16, 2023 and September 23, 2024. Visa operates one the largest digital payment platforms in the world.
By Robbins LLP · Via GlobeNewswire · December 26, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 26, 2024 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 26, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 24, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 24, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Five9, Inc. (NASDAQFIVN) securities, including call options, between June 4, 2024 and August 8, 2024. Five9 provides software for a cloud-based contact center.
By Robbins LLP · Via GlobeNewswire · December 24, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) --
By Robbins LLP · Via GlobeNewswire · December 24, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 24, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds shareholders that a class action was filed on behalf of all investors that purchased or otherwise acquired ASML Holding N.V. (NASDAQASML) ordinary shares between January 24, 2024 and October 15, 2024. ASML is a leading supplier to the semiconductor industry, providing chipmakers with hardware, software, and services to mass produce integrated circuits (i.e., microchips).
By Robbins LLP · Via GlobeNewswire · December 24, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all and entities that purchased or otherwise acquired Joint Stock Company Kaspi.kz (NASDAQKSPT) securities between January 19, 2024 and September 19, 2024. Kaspi.kz has a subsidiary called Kaspi Bank, which it has described as “one of the largest and systematically important financial institutions in Kazakhstan[.]”
By Robbins LLP · Via GlobeNewswire · December 23, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired MGP Ingredients, Inc. (NASDAQMGPI) common stock between May 4, 2023 and October 30, 2024. MGPI is a company that manufactures, distills, and sells alcoholic beverages such as tequila, bourbon, rye, and other whiskeys, as well as grain-neutral spirits such as vodka and gin.
By Robbins LLP · Via GlobeNewswire · December 23, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Applied Therapeutics, Inc. (NASDAQAPLT) securities between January 3, 2024 and December 2, 2024. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases.
By Robbins LLP · Via GlobeNewswire · December 23, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (NASDAQENPH) securities between April 25, 2023 and October 22, 2024. Enphase develops, manufactures, and sells solar microinverters, which are primarily used in residential solar installations to convert solar panel output from direct current to alternating current (which can be transmitted to the power grid).
By Robbins LLP · Via GlobeNewswire · December 23, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Lilium N.V. (NASDAQLILM) securities between June 11, 2024 and November 3, 2024. Lilium is a start-up aviation company engaged in the research and development of an electric vertical takeoff and landing jet.
By Robbins LLP · Via GlobeNewswire · December 20, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Chipotle Mexican Grill, Inc. (NYSECMG) common stock between February 8, 2024 and October 29, 2024, and those who purchased Chipotle call options or sold put options during this time. Chipotle “owns and operates Chipotle Mexican Grill restaurants, which feature a relevant menu of burritos, burrito bowls (a burrito without the tortilla), quesadillas, tacos, and salads.”
By Robbins LLP · Via GlobeNewswire · December 20, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired TMC the metals company Inc. (NASDAQTMC) securities between May 12, 2023 and March 25, 2024. TMC is a deep-sea minerals exploration company focused on the collection, processing, and refining of polymetallic nodules.
By Robbins LLP · Via GlobeNewswire · December 20, 2024
![](https://ml.globenewswire.com/media/f6c754ad-b344-4389-a551-cf97ce05752e/small/robbins-llp-logo-white-background1583450-1-png.png)
SAN DIEGO, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed against Sun Communities, Inc. (NYSESUI) for wrongdoing between February 28, 2019 and September 24, 2024. Sun Communities is a real estate investment company that focuses its investments on manufactured housing communities, recreational vehicle communities, and marinas.
By Robbins LLP · Via GlobeNewswire · December 19, 2024